Vaginal Ring Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, France - Size and Forecast 2024-2028

Published: Dec 2023 Pages: 161 SKU: IRTNTR73124

Vaginal Ring Market 2024-2028

The global vaginal ring market size is estimated to grow by USD 748.36 million at a CAGR of 5.78% between 2023 and 2028. 

Non-contraceptive health benefits is the key factor driving market growth. Contraceptives like vaginal rings are primarily used to prevent pregnancy and are known to be effective. Hormones in vaginal rings offer health benefits like protection against acne, non-cancerous breast growths, ectopic pregnancy, iron deficiency, anemia, endometrial and ovarian cancers, ovarian cysts, premenstrual syndrome (PMS) symptoms, pelvic inflammatory disease, and menstrual-related migraine headaches. The ring eases premenstrual symptoms and makes the period lighter, shorter, and regular. Hence, various non-contraceptive health benefits of vaginal rings will increase their demand for vaginal rings and drive market growth during the forecast period.

Technavio has segmented the market into Distribution Channel, End-user, and Geography 

  • The distribution channel segment includes pharmacies and clinics and online retail
  • The end-user segment includes hospitals, gynecology clinics, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Vaginal Ring Market During the Forecast Period?

To learn more about this report, Download Report Sample

Vaginal Ring Market Segmentation by Distribution Channel, End-user, and Geography Analysis

Application Analysis 

Pharmacies and clinics segment

The market share growth by the pharmacies and clinics segment will be significant during the forecast period. Healthcare professionals, such as gynecologists and family physicians, play a crucial role in the distribution process. They can assess an individual's health history, provide personalized advice, and prescribe the most suitable contraceptive method, including vaginal rings. Several retail pharmacies and hospital pharmacies are located globally. Furthermore, vaginal rings are typically prescription-based contraceptives. Requiring a prescription ensures that individuals receive appropriate medical guidance, reducing the risk of misuse or adverse effects.

Get a glance at the market contribution of various segments Download PDF Sample

The pharmacies and clinics segment was valued at USD 1,412.14 million in 2018. Many health insurance plans cover prescription contraceptives, including vaginal rings. This coverage can reduce the financial burden on individuals, making the method more accessible and affordable. Thus, these factors will promote the growth of the pharmacies and clinics segment and boost the global vaginal ring market during the forecast period.

End-user Analysis

Hospitals

Vaginal rings could be considered as part of postpartum family planning discussions, providing a convenient and effective contraceptive option. Hospitals often have the resources to provide immediate access to contraceptives for individuals who may not have been using a contraceptive method or need a new method after giving birth. Furthermore, hospitals often have counseling services, and healthcare providers can use this opportunity to counsel patients on reproductive health, including contraceptive choices like vaginal rings. This counseling may address individual preferences, side effects, and proper usage. Thus, such factors will drive the growth of the hospitals segment and boost the global vaginal ring market during the forecast period.

Gynecology clinics

Healthcare providers in gynecology clinics may prescribe vaginal rings as part of the treatment plan for conditions such as heavy menstrual bleeding or menstrual disorders. The hormonal components in the ring can help regulate and manage menstrual symptoms. Gynecology clinics provide opportunities for patient education and counseling. Furthermore, gynecology clinics focus on personalized care, and healthcare providers can help women choose contraceptive methods that align with their individual needs, preferences, and health goals. Thus, these factors will drive the growth of the gynecology segment and boost the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 59% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American vaginal ring market is experiencing substantial growth, driven by increasing awareness and product availability, aligning with prevalent market trends and analysis. Educational initiatives on contraceptive methods, including vaginal rings, are fostering adoption among women. Robust public health campaigns promoting family planning and reproductive health contribute to the rising demand for convenient contraceptives. With North America's significant healthcare expenditure, investments in research, development, and marketing strategies for vaginal ring products are driving market trends.

Furthermore, market trends and analysis indicate a strong correlation between high contraceptive awareness, product acceptance, and efficient supply chain management by manufacturers like Pfizer Inc. and Merck & Co. In this landscape, market forecasting anticipates sustained growth. Leading nations, Canada and the US are at the forefront due to heightened awareness and innovative product introductions, positioning the region for continued market growth during the forecast period.

Buy Full Report Now

Key Vaginal Ring Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 16 market companies, including:

AbbVie Inc.: The company offers vaginal rings such as Femring which is used as a treatment of moderate to severe vulvar and vaginal atrophy due to menopause.

  • Allergan
  • Bayer AG
  • Bos Medicare Surgical
  • EUROGINE SL
  • Johnson and Johnson
  • Mayne Pharma Group Ltd.
  • Merck and Co. Inc.
  • Mithra Pharmaceuticals SA
  • Novo Nordisk AS, Pfizer Inc.
  • Prasco Laboratories
  • QPharma Inc.
  • Searchlight Pharma Inc.
  • SMB Corp. of India
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Vaginal Ring Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Vaginal Ring Market Drivers

The growing importance of family planning is the key factor driving market growth. Across the globe, voluntary family planning is gaining traction through the combined efforts of social media and government initiatives, reflecting a promising avenue for market growth and forecasting. Organizations such as the Asia Pacific Council on Contraception, the European Society of Cardiology, and the International Planned Parenthood Federation are actively running programs to raise global awareness about contraceptive drugs and devices. In developing countries, the demand for contraceptives like vaginal rings faces challenges due to reduced awareness and affordability.

However, government initiatives on family planning and improved access to contraceptives, including vaginal rings, are reshaping the landscape. This has resulted in increased popularity among women in developing countries, aiming to mitigate pregnancy-related health risks, unsafe abortions, and adolescent pregnancies. As awareness and the importance of family planning continue to rise, there is a positive correlation with the anticipated market growth and forecasting in the global vaginal ring market during the forecast period.

Significant Vaginal Ring Market Trends

An increase in innovative marketing strategies is one of the market trends shaping market growth. Companies in the healthcare sector are increasingly leveraging digital marketing strategies. This includes maintaining a strong online presence through websites, social media platforms, and targeted online advertising. Digital channels provide opportunities to reach a broader audience and engage with potential users. Campaigns focused on specific demographics like teenagers, women in rural areas, or those with limited access to healthcare, addressing their unique needs and concerns.

Furthermore, informative content through various channels, including websites, brochures, and online webinars, can help raise awareness about the benefits, usage, and safety of vaginal rings.  Innovative packaging and branding can contribute to product differentiation. User-friendly and discreet packaging designs may enhance the appeal of the product to consumers. Clear and informative branding helps to establish trust in the market. Hence, the increase in innovative marketing strategies will drive the growth of the global vaginal ring market during the forecast period.

Major Vaginal Ring Market Challenges

The availability of alternative methods of contraception is a challenge that affects market growth. Awareness and availability of various methods of contraception provide a significant alternative to the vaginal ring market. For example, Copper-T implants, sponges, surgical sterilization, oral contraception, and IUDs are suitable alternatives for vaginal rings. Female condoms are also endorsed by various non-governmental and governmental organizations for family planning. Awareness about the benefits of female contraceptives, like delaying pregnancy to increase the age difference between siblings and achieve desired family sizes, is increasing.

In addition, the choice of convenience is reflected in the costs of these products as they are offered in the market in various price brackets, giving the users the right to choose a contraception method based on their buying power. Moreover, fewer side effects and the flexibility of using these products for longer periods when compared with vaginal rings may lead to an increase in the adoption of alternative contraceptives. Thus, such factors will impede market growth during the forecast period.

Buy Now Full Report

Key Vaginal Ring Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Vaginal Ring Market Customer Landscape

Segment Overview

The vaginal ring market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of market growth and trends from 2018 to 2028. 

  • Distribution Channel Outlook
    • Pharmacies and clinics
    • Online retail
  • Application Outlook
    • Hospitals
    • Gynecology clinics
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Australia
      • Argentina

Vaginal Ring Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.78%

Market Growth 2024-2028

USD 748.36 million

Market structure

Fragmented

YoY growth 2023-2024(%)

5.25

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 59%

Key countries

US, Canada, Germany, UK, and France

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Allergan, Bayer AG, Bos Medicare Surgical, EUROGINE SL, Johnson and Johnson, Mayne Pharma Group Ltd., Merck and Co. Inc., Mithra Pharmaceuticals SA, Novo Nordisk AS, Pfizer Inc., Prasco Laboratories, QPharma Inc., Searchlight Pharma Inc., SMB Corp. of India, Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc.

Market dynamics

Parent market analysis, market research and growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market growth analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Vaginal Ring Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the vaginal ring market forecast between 2024 and 2028
  • Precise estimation of the vaginal ring market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report that will challenge the growth of vaginal ring market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global vaginal ring market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global vaginal ring market 2018 - 2022 ($ million)
    • 4.2 Distribution Channel Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 32: Chart on Comparison by Distribution Channel
      • Exhibit 33: Data Table on Comparison by Distribution Channel
    • 6.3 Pharmacies and clinics - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
    • 6.4 Online retail - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Distribution Channel
      • Exhibit 42: Market opportunity by Distribution Channel ($ million)
      • Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Gynecology clinics - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Canada - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 France - Market size and forecast 2023-2028
      • Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 111: AbbVie Inc. - Overview
              • Exhibit 112: AbbVie Inc. - Product / Service
              • Exhibit 113: AbbVie Inc. - Key news
              • Exhibit 114: AbbVie Inc. - Key offerings
            • 12.4 Bayer AG
              • Exhibit 115: Bayer AG - Overview
              • Exhibit 116: Bayer AG - Business segments
              • Exhibit 117: Bayer AG - Key news
              • Exhibit 118: Bayer AG - Key offerings
              • Exhibit 119: Bayer AG - Segment focus
            • 12.5 Bos Medicare Surgical
              • Exhibit 120: Bos Medicare Surgical - Overview
              • Exhibit 121: Bos Medicare Surgical - Key offerings
            • 12.6 EUROGINE SL
              • Exhibit 122: EUROGINE SL - Overview
              • Exhibit 123: EUROGINE SL - Product / Service
              • Exhibit 124: EUROGINE SL - Key offerings
            • 12.7 Johnson and Johnson
              • Exhibit 125: Johnson and Johnson - Overview
              • Exhibit 126: Johnson and Johnson - Business segments
              • Exhibit 127: Johnson and Johnson - Key news
              • Exhibit 128: Johnson and Johnson - Key offerings
              • Exhibit 129: Johnson and Johnson - Segment focus
            • 12.8 Mayne Pharma Group Ltd.
              • Exhibit 130: Mayne Pharma Group Ltd. - Overview
              • Exhibit 131: Mayne Pharma Group Ltd. - Business segments
              • Exhibit 132: Mayne Pharma Group Ltd. - Key news
              • Exhibit 133: Mayne Pharma Group Ltd. - Key offerings
              • Exhibit 134: Mayne Pharma Group Ltd. - Segment focus
            • 12.9 Merck and Co. Inc.
              • Exhibit 135: Merck and Co. Inc. - Overview
              • Exhibit 136: Merck and Co. Inc. - Business segments
              • Exhibit 137: Merck and Co. Inc. - Key news
              • Exhibit 138: Merck and Co. Inc. - Key offerings
              • Exhibit 139: Merck and Co. Inc. - Segment focus
            • 12.10 Mithra Pharmaceuticals SA
              • Exhibit 140: Mithra Pharmaceuticals SA - Overview
              • Exhibit 141: Mithra Pharmaceuticals SA - Product / Service
              • Exhibit 142: Mithra Pharmaceuticals SA - Key offerings
            • 12.11 Novo Nordisk AS
              • Exhibit 143: Novo Nordisk AS - Overview
              • Exhibit 144: Novo Nordisk AS - Business segments
              • Exhibit 145: Novo Nordisk AS - Key offerings
              • Exhibit 146: Novo Nordisk AS - Segment focus
            • 12.12 Pfizer Inc.
              • Exhibit 147: Pfizer Inc. - Overview
              • Exhibit 148: Pfizer Inc. - Product / Service
              • Exhibit 149: Pfizer Inc. - Key news
              • Exhibit 150: Pfizer Inc. - Key offerings
            • 12.13 Prasco Laboratories
              • Exhibit 151: Prasco Laboratories - Overview
              • Exhibit 152: Prasco Laboratories - Product / Service
              • Exhibit 153: Prasco Laboratories - Key offerings
            • 12.14 QPharma Inc.
              • Exhibit 154: QPharma Inc. - Overview
              • Exhibit 155: QPharma Inc. - Product / Service
              • Exhibit 156: QPharma Inc. - Key offerings
            • 12.15 SMB Corp. of India
              • Exhibit 157: SMB Corp. of India - Overview
              • Exhibit 158: SMB Corp. of India - Product / Service
              • Exhibit 159: SMB Corp. of India - Key offerings
            • 12.16 Teva Pharmaceutical Industries Ltd.
              • Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.17 TherapeuticsMD Inc.
              • Exhibit 165: TherapeuticsMD Inc. - Overview
              • Exhibit 166: TherapeuticsMD Inc. - Product / Service
              • Exhibit 167: TherapeuticsMD Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              vaginal ring market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis